Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aα
- 1 November 2006
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 5 (11) , 2727-2736
- https://doi.org/10.1158/1535-7163.mct-06-0273
Abstract
Cantharidin, a natural vesicant, inhibits the activity of several PPP family phosphatases, displays antitumor activity, and induces apoptosis in many types of tumor cells. However, the molecular mechanisms underlying the antitumor activity of cantharidin are not clear. Here, dose-response studies confirm a strong correlation between the suppression of phosphatase activity and cell death. Flow cytometry analysis indicates that before apoptosis, cantharidin delays cell cycle progression following DNA replication with no apparent effect on G1-S or S-G2 phase progression. In contrast, studies with double thymidine-synchronized populations of cells indicate that cantharidin can rapidly arrest growth when added during G2 or early M phase. Immunostaining indicates that cell cycle arrest occurs before the completion of mitosis and is associated with the appearance of aberrant mitotic spindles. Live cell imaging with time-lapse microscopy shows that cantharidin disrupts the metaphase alignment of chromosomes and produces a prolonged mitotic arrest, with the onset of apoptosis occurring before the onset of anaphase. To explore the contribution of individual phosphatases, antisense oligonucleotides and small interfering RNA were developed to suppress the expression of cantharidin-sensitive phosphatases. The suppression of PP2Aα, but not PP2Aβ, is sufficient to induce metaphase arrest, during which time lagging chromosomes are observed moving between the spindle poles and the metaphase plate. Immunostaining revealed slightly abnormal, yet predominately bipolar, mitotic spindles. Nonetheless, after a 10- to 15-hour delay, the cells enter anaphase, suggesting that an additional cantharidin-sensitive phosphatase is involved in the progression from metaphase into anaphase or to prevent the onset of apoptosis in cells arrested during mitosis. [Mol Cancer Ther 2006;5(11):2727–36]Keywords
This publication has 36 references indexed in Scilit:
- PP2A Is Required for Centromeric Localization of Sgo1 and Proper Chromosome SegregationDevelopmental Cell, 2006
- Cantharidin-induced cytotoxicity and cyclooxygenase 2 expression in human bladder carcinoma cell lineToxicology, 2006
- Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis INature, 2006
- Structural Basis for the Catalytic Activity of Human Serine/Threonine Protein Phosphatase-5Journal of Biological Chemistry, 2004
- Use of Antisense Oligonucleotides: Advantages, Controls, and Cardiovascular TissueMicrocirculation, 2002
- Anhydride modified cantharidin analogues: synthesis, inhibition of protein phosphatases 1 and 2A and anticancer activityBioorganic & Medicinal Chemistry Letters, 2000
- Serine/Threonine Protein Phosphatase Type 1γ1 Is Required for the Completion of Cytokinesis in Human A549 Lung Carcinoma CellsJournal of Biological Chemistry, 2000
- Identification and Characterization of Second-Generation Antisense OligonucleotidesAntisense and Nucleic Acid Drug Development, 1997
- Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2AFEBS Letters, 1993
- Tubulin interaction with kinetochore proteins: analysis by in vitro assembly and chemical cross-linking.The Journal of cell biology, 1987